Chris Hulls - Mar 8, 2023 Form 4 Insider Report for Life360, Inc. (LIFX)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Menudier, as Attorney-in-Fact
Stock symbol
LIFX
Transactions as of
Mar 8, 2023
Transactions value $
-$29,769
Form type
4
Date filed
3/10/2023, 02:19 PM
Previous filing
Dec 12, 2022
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFX Common stock Tax liability -$29.8K -2.91K -0.1% $10.23* 3.02M Mar 8, 2023 Direct F1, F2
holding LIFX Common stock 30K Mar 8, 2023 Held by ICCA Labs, LLC F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
F2 Includes 1,686,552 shares of the Issuer's common stock underlying 5,059,656 Chess Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, thecompany that operates the ASX. Also includes 75,474 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F3 Represents shares of the Issuer's common stock underlying 89,880 CDIs.
F4 The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC.